| Name | Title | Contact Details |
|---|
Argon Medical Devices, Inc. (Argon), founded in 1972 is a leading manufacturer and supplier of single-use Vascular Access Devices. Argon's products are divided into Cardiology, Radiology and Critical Care product lines. Argon supplies disposable
Cardon Outreach works tirelessly to reduce the financial burden of medical bills on Americans and on the healthcare providers who serve them. Our work makes a positive difference to thousands of people and hundreds of hospitals and clinics, in communities all over the nation, every day. It is this mission that enables our success at over 800 facilities across 39 states. Over our 20+ years of service we have helped over 24 million individuals, translating into over $100 billion dollars in healthcare spend. Our technology driven, innovative approach to the revenue cycle is prepared to overcome the challenges of the Affordable Care Act. Through our approach to hiring and developing the right people and our sophisticated proprietary technology, MPower, we improve the patient experience, improve your facility`s reputation, reduce A/R days, increase cash-on-hand, and provide on demand proof-of-compliance.
Circaid Medical Products Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medtech Surgical Inc is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.